Worth reading
85Important
Scored from 3 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
-825
¥ millionWording
Definitive
How definitive the wording is.Revised forecast
Fiscal year ended March 2025 · Full yearPrevious forecast published 2025 年２月 13 日Net Sales9,490→9,304million
-2.0%
Operating profit-180→-342million
-90.0%
Ordinary income-120→-275million
-129.2%
Profit attributable to owners of the parent-70→-895million
-1,178.6%
Net income per share-8.67→-110.77yen and sen
-1,177.6%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
ファインケミカル事業及び難燃剤事業における販売が想定より減少し、原材料費等の売上原価も増加したことに加え、難燃剤事業における収益状況悪化の影響で生産設備等の減損損失516百万円を特別損失に計上したため。
Details and amount of extraordinary loss
生産設備等の減損損失516百万円
Previous-period results売上高 9,686百万円、営業利益 △105百万円、経常利益 △10百万円、親会社株主に帰属する当期純利益 82百万円、１株当たり当期純利益 10.30円 銭
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | ¥9,490 million → ¥9,304 million（-2.0%） |
| Operating profit | ¥-180 million → ¥-342 million |
| Ordinary income | ¥-120 million → ¥-275 million |
| Profit attributable to owners of the parent | ¥-70 million → ¥-895 million |
| Net income per share | -8.67 yen and sen → -110.77 yen and sen |
| Fiscal Period Covered | Fiscal year ended March 2025 |
| Period Covered | Full year |
| Publication date of previous forecast | 2025 年２月 13 日 |
| Previous-period results | 売上高 9,686百万円、営業利益 △105百万円、経常利益 △10百万円、親会社株主に帰属する当期純利益 82百万円、１株当たり当期純利益 10.30円 銭 |
| Reason for the revision | ファインケミカル事業及び難燃剤事業における販売が想定より減少し、原材料費等の売上原価も増加したことに加え、難燃剤事業における収益状況悪化の影響で生産設備等の減損損失516百万円を特別損失に計上したため。 |
| Details and amount of extraordinary loss | 生産設備等の減損損失516百万円 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
Dividend forecast revision
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.ファインケミカル事業と難燃剤事業の販売が想定より減少し、原材料費等の売上原価も増加したため、売上高・営業利益・経常利益が減少した。また、難燃剤事業の収益状況悪化により、生産設備等の減損損失516百万円を特別損失に計上し、当期純利益も減少した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.